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Case Report

Extraskeletal chondroblastic osteosarcoma of the subcutaneous tissue in a Maltese dog
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Abstract: A 10-year-old spayed female Maltese dog presented to a local animal hospital with a subcutaneous mass (4 × 3 × 3 cm) in
the right shoulder region. The mass was well circumscribed, with soft tissue opacity and variable levels of mineralization, but with no
bony involvement in radiography. The mass was surgically removed. Upon histological examination, the mass consisted of malignant
mesenchymal cells that had produced a chondroid matrix and osteoid. Round to polygonal neoplastic cells with large nuclei showed
moderate anisokaryosis and variable numbers of mitotic figures. The tumor cells were positive for vimentin and osteocalcin and negative
for pancytokeratin, S100, and C-kit. On the basis of histopathologic and immunohistochemical features, the tumor was diagnosed as an
extraskeletal chondroblastic osteosarcoma.
Key words: Dogs, extraskeletal osteosarcoma, soft tissue, chondroblastic osteosarcoma, immunohistochemistry

1. Introduction
Extraskeletal osteosarcoma is defined as an osteoidproducing mesenchymal tumor with no skeletal
involvement (1). Extraskeletal osteosarcomas are highly
malignant and extremely rare, comprising only 1% of
all osteosarcomas excluding those of mammary gland
origin (1–3). Of the few canine cases reported in the
subcutaneous tissues and extremities, the majority of cases
have been reported in larger breeds of dog, with no reports
specifically involving small-breed dogs.
Since the number of cases reported is extremely low,
here we describe a case of an extraskeletal osteosarcoma
in the skin of a Maltese dog, a small breed, which is of
considerable interest.
2. Case history
A 10-year-old spayed female Maltese dog weighing 4.7 kg
presented to a local animal hospital with a soft tissue mass
in the right shoulder area. Radiographically (Figure 1),
the mass was well circumscribed, with soft tissue opacity
and variable levels of mineralization, but with no bony
involvement. There was no enlargement of the axillary
lymph node or thorax lymph node. Upon review of the
medical records, the dog had no history of injections in that
area before the mass was found. The mass was surgically
* These authors contributed equally to this work.
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removed under general anesthesia. An encapsulated
mass was located beneath the dermis and was completely
removed with enough margin.
For definitive diagnosis, the excised mass was fixed in
a 10% buffered formalin solution before being routinely
processed and embedded in paraffin. The mass was sent
to the Department of Veterinary Pathology, College of
Veterinary Medicine, Konkuk University. Macroscopically,
the pale white mass was well circumscribed and firm
(approximately 4 × 4 × 3 cm), but could readily be cut by
a blade without prior decalcification (Figure 2). Sections
were cut and stained with hematoxylin and eosin (H&E) for
evaluation of histological features, while others were stained
with Alcian blue for detection of the chondroid matrix. For
immunohistochemical examination, primary antibodies
to pancytokeratin (M3515; Agilent Technologies, Santa
Clara, CA, USA), vimentin (M0725; Agilent Technologies),
osteocalcin (NB600-1394; Novus Biologicals, Littleton,
CO, USA), S100 (Z0311; Agilent Technologies), and C-kit
(A4502; Agilent Technologies) were used. Deparaffinized
slides were rehydrated with PBS and incubated in 3%
hydrogen peroxide for 20 min. Heat-induced antigen
retrieval was performed in Tris-EDTA (pH 9.0) for the
detection of vimentin, C-Kit, and osteocalcin and in citric
acid (pH 6.0) for detection of pancytokeratin using a
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Figure 1. Radiograph of subcutaneous mass excised from a Maltese dog. A wellcircumscribed mass was detected, with soft tissue opacity and variable levels of
mineralization with no bony involvement.

Figure 2. Cut surface of a formalin-fixed mass excised from a
Maltese dog. The pale white mass was well circumscribed and
firm (approximately 4 × 4 × 3 cm). Bar = 1 cm.

Figure 3. Subcutaneous mass excised from a Maltese dog.
Polygonal neoplastic cells were observed around the osteoid matrix
(asterisks). Osteoblasts with prominent nucleoli and mitotic figures
(arrowhead) are visible. H&E staining. Bar = 50 µm.

microwave oven at high power. Antigen retrieval was not
performed for the S100 antibody. After blocking with 5%
normal goat serum for 30 min at room temperature, the
slides were individually incubated with each of the primary
antibodies: the slides were washed three times in PBS and
incubated with horseradish peroxidase secondary antibodies
(K5007; Agilent Technologies) for 40 min. All slides were
counterstained with Gill’s hematoxylin. Positive control
tissue sections were included for each antibody, and isotypematched immunoglobulins were used as negative controls.

components in nearly equal volumes. Chondroid tissue
formed by abnormal chondroblastic cells showed a moderate
degree of anisokaryosis with vacuolated cytoplasm and
large nucleoli. Polygonal cells with prominent nucleoli
showed a moderate degree of anisokaryosis, and these
had formed the osteoid components (Figure 3). There
were minimal numbers of inflammatory cells. There were
three to four mitotic figures per 40× high-power field.
The chondroid material stained positive with Alcian
blue (Figure 4a). Immunohistochemical analysis showed
that most neoplastic cells were positive for vimentin
(Figure 4b) and osteocalcin (Figure 4c) and negative
for pancytokeratin, S100 (Figure 4d), and C-kit. On the
basis of these findings, the tumor was diagnosed as an
extraskeletal chondroblastic osteosarcoma.

3. Results and discussion
Microscopically, the mass consisted of malignant
mesenchymal cells that had produced a chondroid
matrix and osteoid, with chondroblastic and osteoblastic
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Figure 4. Subcutaneous tissue mass excised from a Maltese dog. The chondroid material show positive staining reaction with Alcian blue
(a). Immunohistochemical analysis showed that most neoplastic cells were positive for vimentin (b) and osteocalcin (c) and negative
for S100 (d). Bar = 50 µm.

Osteosarcomas are malignant mesenchymal tumors
that produce osteoid (2,4). Osteosarcoma accounts for 85%
of malignant primary bone tumors in dogs (5,6), commonly
occurring in middle-aged to older dogs and in large breeds
(4). In one study, giant breeds of dog (>36 kg in weight)
and large breeds (18‒36 kg) were demonstrated to have a
much higher probability of developing osteosarcoma than
small breeds (<9 kg) (7).
Extraskeletal osteosarcoma is a malignant mesenchymal
tumor that produces either osteoid or cartilage in the
viscera or soft tissues, with no bone involvement (2). It is a
rare tumor in dog, excluding tumors originating from the
mammary gland (1,2). In contrast to human cases, most
canine extraskeletal osteosarcomas arise from the viscera
rather than from the subcutaneous tissues (2). Of the few
canine cases reported in the subcutaneous tissues, one
report described cases involving four dogs (1) and another
occurred in a 7-year-old spayed female Labrador retriever
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(3), while the most recently reported cases were in seven
dogs (8), in an 11-year-old spayed female Labrador
retriever (associated with a retained surgical sponge)
(9), and in a 6-year-old spayed female Labrador retriever
(associated with injection) (10). The majority of cases have
thus been reported in larger breeds of dog, with no reports
specifically involving smaller breeds.
Injection-site sarcomas commonly occur in cats but
are rare in dogs (11). In this case, there is no evidence of
chronic inflammation due to injection with no history of
injection according to the medical records. In addition,
histologic findings that can be commonly found in
injection-site sarcomas such as central necrosis rimmed
by inflammation and macrophages containing adjuvant
materials were not observed. Based on these results, it
was determined that the tumor was not associated with
injection.
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To the authors’ knowledge, this is the first report
of primary subcutaneous extraskeletal chondroblastic
osteosarcoma in a Maltese dog. Among reports published
in the 21st century, only a few cases of subcutaneous
extraskeletal osteosarcoma were documented, all of
which occurred in large or unspecified breeds of dog or
unspecified locations (8,10). Since the location of the tumor
is very unusual, the differential diagnosis of extraskeletal
osteosarcoma in subcutaneous tissue may be missed if no
calcification is observed radiographically. Furthermore, as
extraskeletal osteosarcoma is a malignant tumor, accurate
diagnosis is very important for prolonged survival of
the dog. If calcification is observed radiographically,
the possibility of extraskeletal osteosarcoma should be
considered and the excised mass should be evaluated
histologically and immunohistochemically to obtain an
accurate diagnosis. In this case, 4 months after the surgical

removal, the tumor recurred at the same site and was
confirmed as a result of biopsy.
In our report, we describe an extraskeletal
osteosarcoma arising in a small breed of dog (Maltese),
with radiographically evident calcification, for which we
performed histopathological and immunohistochemical
diagnosis. This finding suggests that, although
subcutaneous extraskeletal osteosarcoma in a small breed of
dog is extremely rare, it is important to be aware of possible
differential diagnoses. In addition, immunohistochemical
staining as performed in this study will help to confirm the
diagnosis of extraskeletal osteosarcoma.
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